News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Institute for Clinical Excellence (NICE) Backs Allergan Inc. (AGN)''s Botox for Some Migraine Sufferers


5/11/2012 7:05:11 AM

The cost regulator for the U.K.'s publicly-funded National Health Service has reversed its earlier stance on U.S.-based Allergan Inc.'s (AGN) wrinkle-fighting drug Botox and now recommends its use for some patients suffering from migraine headaches. The independent National Institute for Health and Clinical Excellence Friday said in final draft guidance that its advisory committee now recommends use of the injected medicine, known chemically as botulinum toxin type A, for some adult patients with chronic migraine, after NICE received more information on the product from the company. The body had previously said it was not convinced of the value of funding the therapy on the NHS.

Read at Fox News
Read at Reuters
Read at Press Assoc. (PA)


comments powered by Disqus
   
Migraine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES